State of Wisconsin Investment Board lessened its holdings in Danaher Corporation (NYSE:DHR) by 7.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 659,926 shares of the conglomerate’s stock after selling 52,529 shares during the period. State of Wisconsin Investment Board owned about 0.09% of Danaher Corporation worth $56,608,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of DHR. GQG Partners LLC purchased a new stake in Danaher Corporation during the 2nd quarter worth $101,000. Proficio Capital Partners LLC increased its stake in Danaher Corporation by 92.3% during the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after buying an additional 598 shares during the period. Monetary Management Group Inc. increased its stake in Danaher Corporation by 10.7% during the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after buying an additional 150 shares during the period. Acrospire Investment Management LLC increased its stake in Danaher Corporation by 185.5% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after buying an additional 1,100 shares during the period. Finally, Motco increased its stake in Danaher Corporation by 8.8% during the 2nd quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after buying an additional 163 shares during the period. 75.56% of the stock is currently owned by institutional investors and hedge funds.
In other Danaher Corporation news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the completion of the transaction, the chief executive officer now directly owns 271,737 shares of the company’s stock, valued at approximately $25,173,715.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The disclosure for this sale can be found here. Insiders have sold a total of 317,498 shares of company stock valued at $28,838,801 over the last three months. 12.20% of the stock is currently owned by company insiders.
Danaher Corporation (NYSE DHR) opened at $93.30 on Monday. Danaher Corporation has a fifty-two week low of $76.27 and a fifty-two week high of $93.86. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. The company has a market cap of $64,899.96, a PE ratio of 23.99, a PEG ratio of 2.22 and a beta of 1.02.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.87 EPS. analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend was Thursday, September 28th. Danaher Corporation’s payout ratio is 16.52%.
COPYRIGHT VIOLATION WARNING: This news story was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://stocknewstimes.com/2017/11/20/state-of-wisconsin-investment-board-cuts-stake-in-danaher-corporation-dhr.html.
Several research firms recently issued reports on DHR. Robert W. Baird lifted their price target on shares of Danaher Corporation from $87.00 to $97.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. Credit Suisse Group raised their price objective on shares of Danaher Corporation from $93.00 to $96.00 and gave the stock an “outperform” rating in a report on Friday, October 20th. Morgan Stanley raised their price objective on shares of Danaher Corporation from $95.00 to $98.00 and gave the stock an “overweight” rating in a report on Friday, October 20th. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a report on Thursday, October 5th. Finally, J P Morgan Chase & Co reissued an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a report on Friday, September 8th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. Danaher Corporation currently has a consensus rating of “Buy” and a consensus target price of $93.31.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.